Trials / Completed
CompletedNCT01931982
Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
Effect of GLP-1 on Microvascular Myocardial Function in Patients With Type 2
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Bispebjerg Hospital · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if a GLP-1 agonist improves microvascular perfusion in the heart of patients with type 2 diabetes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Victoza |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-08-30
- Last updated
- 2014-06-25
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01931982. Inclusion in this directory is not an endorsement.